Linear focal elastosis

Linear focal elastosis is a skin condition that is characterized by yellowish or flesh-colored linear bands on the skin. These bands are typically found on the lower back and are caused by an accumulation of elastin in the dermis. The condition is most commonly found in elderly individuals, but it can also occur in younger people. The exact cause of linear focal elastosis is unknown, but it is thought to be related to sun exposure and aging.

Symptoms

The primary symptom of linear focal elastosis is the presence of yellowish or flesh-colored linear bands on the skin. These bands are typically found on the lower back, but they can also appear on other parts of the body. The bands are usually asymptomatic, meaning they do not cause any discomfort or pain. However, some individuals may experience mild itching or irritation.

Causes

The exact cause of linear focal elastosis is unknown. However, it is thought to be related to sun exposure and aging. The condition is most commonly found in elderly individuals, but it can also occur in younger people. Some researchers believe that the condition may be caused by a genetic predisposition.

Diagnosis

Linear focal elastosis is typically diagnosed through a physical examination and a review of the patient's medical history. In some cases, a skin biopsy may be performed to confirm the diagnosis. The biopsy will show an accumulation of elastin in the dermis, which is a characteristic feature of this condition.

Treatment

There is currently no cure for linear focal elastosis. Treatment is typically focused on managing the symptoms and preventing further damage to the skin. This may include the use of topical creams or lotions to soothe any itching or irritation. In some cases, laser therapy may be used to improve the appearance of the skin.

See also

• Elastosis
• Dermis
• Skin biopsy

Linear focal elastosis Resources
Need Help Finding a Doctor? WikiMD's DocFinder can help find general and specialist physicians.	Latest articles Most recent articles Ongoing trials.